Biotechnology News

March 14, 2012

ALPHARETTA, Ga.--(BUSINESS WIRE)--SANUWAVE Health, Inc. (OTCBB: SNWV) today reported financial results and accomplishments for the year ended December 31, 2011, and provided an update on the U.S. Food and Drug Administration (FDA) status of the...

March 14, 2012

ORLANDO, Fla.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced that its Thermo Scientific Easy-nLC 1000 has received a Scientist’s Choice Award from SelectScience, the leading online resource...

March 14, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq:AFFY) today reported financial results for the year ended December 31, 2011. The net loss for the year ended December 31, 2011 was $61.4 million compared to a net loss of $14.1 million for...

March 14, 2012

ZURICH & LUGANO, Switzerland & TORONTO--(BUSINESS WIRE)--EBD Group and SocialFinance.ca have joined together on behalf of Partnering for Global Impact® 2012 to deliver a live webinar on impact investing

March 14, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Nanotech Commercialization Conference (Durham, NC, April 4 - 5) to host "The Art of the Small" - a juried art exhibition of works inspired by nano tech, nano biotech, genomics, DNA and genetics.

March 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced a registered offering of $675 million of its 3.125% Senior Notes due 2022 and $400 million of its 4.50% Senior Notes due 2042 (collectively, the "Notes"). Medtronic intends...

March 14, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Starkey Hearing Technologies is proud that its AMP hearing aid has been honored with a red dot award: product design 2012.

March 14, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced that Gedeon Richter Spain is deploying the award winning, pharma-specific Customer Relationship Management (CRM) solution, Mobile Intelligence™, via SaaS for their Specialty...

March 14, 2012

FREIENBACH, Switzerland--(BUSINESS WIRE)--FDA approves BINOSTO, First and Only Effervescent Osteoporosis Treatment in a Buffered Solution : Proven Fracture Risk Reduction of Alendronate at the Hip and Spine

March 14, 2012

LIBERTYVILLE, Ill.--(BUSINESS WIRE)--Valent BioSciences Corporation (VBC) announced today it signed a joint testing agreement with Pace International, LLC that will expand a screening and evaluation collaboration between the two companies into...

March 14, 2012

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate announced a research collaboration with Merck focused on using proprietary algorithms and cloud computing to generate new small molecule drug leads against a cardiovascular disease target.

March 14, 2012

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc., and its subsidiary American Renal Holdings Inc. announced results today for the quarter ended December 31, 2011. Financial and operating highlights include: Revenues –...

March 14, 2012

ANDOVER, Mass.--(BUSINESS WIRE)--Capsule is exhibiting at AONE 45th Annual Meeting and Exposition, March 21-24, 2012 in Boston for nurse leaders to discuss the benefits of medical device connectivity and its impact on patient care.

March 14, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.225 per ordinary share.

March 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on bringing environmentally sustainable solutions to the plastics, chemicals and energy industries, today announced that it has granted a non-...

March 14, 2012

BOSTON--(BUSINESS WIRE)--HighRes Biosolutions announces ACell, a brand new bench top laboratory automation system that’s small and safe enough for the bench top, yet flexible enough to integrate with HighRes' storage devices.

March 14, 2012

SAN MARINO, Calif.--(BUSINESS WIRE)--Cites Pre-IND Filing with FDA for Lyme Disease, Oncology &HIV Drugs in Pipeline, and Progress in Algal BioFuel Subsidiary, VG Energy

March 14, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that C. Martin Harris, MD, MBA, has been elected to its board of directors, effective March 30, bringing the company’...

March 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera announces 2011 fourth quarter and full year results

March 14, 2012

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that on Monday, March 12 it filed with the Securities and Exchange Commission a proxy...

March 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, today reported financial results for the...

March 14, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Predictive Biosciences today announced that the Company will be presenting at GTCbio’s 4th Oncology Biomarkers Conference, to be held March 15 – 16 in San Diego, CA. Anthony P. Shuber, Predictive Biosciences’...

March 14, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (KYTHERA), a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, today announced the appointment of...

March 14, 2012

SAFFRON WALDEN & HARLOW, England & MÖLNDAL, Sweden--(BUSINESS WIRE)--Pharma CRO drug discovery deal focusing on respiratory and infammatory diseases

March 14, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Promising New Parkinson’s Therapies May Also Treat Brain Injuries

March 14, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Okairos has announced the initiation of a Phase I/II clinical trial evaluating its vaccine against the hepatitis C virus

March 13, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received a request for additional information, often referred to as a “second request,” from the Federal Trade Commission (“FTC”) in connection...

March 13, 2012

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced financial results for the year ended December 31, 2011 and additional corporate highlights. As of December 31, 2011, BioSante’s cash balance was...

March 13, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that for the period of March 12, 2012 to September 11, 2012, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon...

March 13, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2011 Financial and Operating Results

March 13, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) announced today its financial results for the fourth quarter and year ended December 31, 2011. “In 2011, we completed enrollment in two Phase 3 trials of tavaborole in...

March 13, 2012

FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. Reports Fourth Quarter and Year-End 2011 Earnings Results

March 13, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting.

March 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today highlighted its clinical and financial outlook and announced its full-year and fourth quarter 2011 financial results. During the quarter, Infinity continued to...

March 13, 2012

DENVER--(BUSINESS WIRE)--John Parrish Appointed Chairman of ValveXchange, Inc.

March 13, 2012

ST. LOUIS--(BUSINESS WIRE)--Certara announces completion of Simcyp acquisition, plans to integrate Simcyp's highly-regarded technologies into planned Certara translational science initiatives.

March 13, 2012

ARLINGTON, Va.--(BUSINESS WIRE)--A comprehensive analysis of the commercial, pre-made antibodies market. Includes market share, competitive positioning, customer satisfaction, researchers’ needs, and "best-in-class" suppliers.

March 13, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) discussed the Cell-in-a-Box® technology, from SG Austria, and its potential use to treat downstream micro metastatic disease.

March 13, 2012

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today raised approximately $381 million in net proceeds from the sale of 76% (24.15 million ordinary shares) of its shareholding in Alkermes plc (NASDAQ: ALKS), net of underwriter fees....

March 13, 2012

CENTENNIAL, Colo.--(BUSINESS WIRE)--Cell>Point has received a letter from the FDA indicating agreement on a Special Protocol Assessment for Cell>Point’s Phase 3 pivotal study of its cancer molecular imaging agent, technetium-99m-EC-G.

March 13, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. emergency department physicians and pharmacy and therapeutic...

March 13, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is excited to be embarking on a medical marijuana documentary project. Pre-...

March 13, 2012

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) (“Alkermes”) today announced the completion of an underwritten public offering of 24,150,000 ordinary shares held by a subsidiary of Elan Corporation, plc (“Elan”) at a price to the public of $...

March 13, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Celerant Consulting, Inc., a leading management consulting firm focused on Operational Strategy and Implementation, announced today that Michael L Keech joined the firm as Senior Vice President and Americas...

March 13, 2012

EXTON, Penn.--(BUSINESS WIRE)--In a recent TreatmentTrends® study with US gastroenterologists, BioTrends Research Group, LLC finds that the use of anti-TNF biologic agents in the treatment of Crohn’s Disease (CD) has increased over the past six...

March 13, 2012

WINDHAM, Maine--(BUSINESS WIRE)--Maine Standards Company, LLC, receives FDA clearance for VALIDATE® VIT D calibration verification / linearity test kit.

March 13, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the pricing of its offering of $600 million aggregate principal amount of 1.5% convertible senior notes due 2019 to qualified institutional buyers pursuant...

March 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced the appointment of three distributors in China, Korea and Indonesia for its Presage ST2 Assay. The company...